Nutrineal Solution for Peritoneal Dialysis 4 with 1.1% amino acids
- Name:
Nutrineal Solution for Peritoneal Dialysis 4 with 1.1% amino acids
- Company:
Baxter Holding B.V.
- Active Ingredients:
Alanine, Arginine, Calcium Chloride Dihydrate, Glycine, Histidine, Isoleucine, Leucine, Lysine hydrochloride, Magnesium chloride, hexahydrate, Methionine, Phenylalanine, Proline, Serine, Sodium Chloride, Sodium Lactate, Threonine, Tryptophan, Tyrosine, Valine
- Legal Category:
Product subject to medical prescription which may not be renewed (A)
Click on this link to Download PDF directly
Baxter Holding B.V.
Company Products
When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.
Updated on 2 April 2019 SmPC
Reasons for updating
- Change to section 7 - Marketing authorisation holder
- Change to section 8 - Marketing authorisation number(s)
- Change to section 10 - Date of revision of the text
Legal category: Product subject to medical prescription which may not be renewed (A)
Updated on 27 December 2017 PIL
Reasons for updating
- Change to section 2 - Qualitative and quantitative composition
- Change to section 4.8 - Undesirable effects
- Change to section 6.4 - Special precautions for storage
- Change to section 10 - Date of revision of the text
Free text change information supplied by the pharmaceutical company
Section 4.8 - addition reporting of suspected adverse reactions statement.
Section 6.4 - change in storage instructions - Keep in outer carton in order to protect from light.
Updated on 27 December 2017 SmPC
Reasons for updating
- Change to section 2 - Qualitative and quantitative composition
- Change to section 4.8 - Undesirable effects
- Change to section 6.4 - Special precautions for storage
- Change to section 10 - Date of revision of the text
Legal category: Product subject to medical prescription which may not be renewed (A)
Free text change information supplied by the pharmaceutical company
Section 4.8 - addition reporting of suspected adverse reactions statement.
Section 6.4 - change in storage instructions - Keep in outer carton in order to protect from light.
Updated on 27 December 2017 SmPC
Reasons for updating
- New SmPC for new product
Legal category: Product subject to medical prescription which may not be renewed (A)
Updated on 1 September 2016 PIL
Reasons for updating
- New SPC for medicines.ie
Free text change information supplied by the pharmaceutical company
Updated on 1 September 2016 SmPC
Reasons for updating
- New SPC for medicines.ie
Legal category: Product subject to medical prescription which may not be renewed (A)